PMPRB proposes new medicine price review process in interim guidance
The Patented Medicine Prices Review Board (PMPRB) has invited stakeholders to comment on a proposal to conduct interim price reviews on new medicines, pending the development of new guidelines....To view the full article, register now.
Already a subscriber? Click here to view full article